Nautilus Biotechnology, Inc.
NAUT
$2.08
$0.105.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -13.87% | -19.75% | -15.78% | -5.02% | -3.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.99% | -17.76% | -12.79% | -0.10% | 0.13% |
| Operating Income | 18.99% | 17.76% | 12.79% | 0.10% | -0.13% |
| Income Before Tax | 17.46% | 16.53% | 11.30% | -3.35% | -3.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.46% | 16.53% | 11.30% | -3.35% | -3.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.46% | 16.53% | 11.30% | -3.35% | -3.58% |
| EBIT | 18.99% | 17.76% | 12.79% | 0.10% | -0.13% |
| EBITDA | 19.04% | 17.94% | 12.86% | -0.52% | 0.12% |
| EPS Basic | 18.00% | 17.12% | 12.02% | -2.72% | -3.15% |
| Normalized Basic EPS | 17.95% | 17.15% | 11.98% | -2.95% | -3.15% |
| EPS Diluted | 18.00% | 17.12% | 12.02% | -2.72% | -3.15% |
| Normalized Diluted EPS | 17.95% | 17.15% | 11.98% | -2.95% | -3.15% |
| Average Basic Shares Outstanding | 0.68% | 0.71% | 0.81% | 0.65% | 0.42% |
| Average Diluted Shares Outstanding | 0.68% | 0.71% | 0.81% | 0.65% | 0.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |